Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Children With ASD and GI Symptoms
NCT07105267Phase 2Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2025
- Primary completion
- Apr 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of fecal microbiome transplant in Autism Spectrum Disorder (ASD), gastrointestinal disorders, sponsored by Assistance publique - Hôpitaux de Paris. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
fecal microbiome transplant
03
Conditions
Autism Spectrum Disorder (ASD)gastrointestinal disorders
Beyond the preview
Go deeper on NCT07105267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07105267.